Access the full text.
Sign up today, get DeepDyve free for 14 days.
Xing-Mei Han, Dong-Sheng Ouyang, Pei-Xin Lu, Chang-Hong Jiang, Yan Shu, Xiao-Ping Chen, Z. Tan, Hong-Hao Zhou (2001)
Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2.Pharmacogenetics, 11 5
L. Bertilsson, J. Carrillo, M. Dahl, A. Llerena, C. Alm, U. Bondesson, Leif Lindstrom, Inmaculada Rubia, S. Ramos, J. Benítez (1994)
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.British journal of clinical pharmacology, 38 5
M. Chida, T. Yokoi, T. Fukui, M. Kinoshita, J. Yokota, T. Kamataki (1999)
Detection of Three Genetic Polymorphisms in the 5′‐Flanking Region and Intron 1 of Human CYP1A2 in the Japanese PopulationJapanese Journal of Cancer Research : Gann, 90
Y. Obase, T. Shimoda, T. Kawano, S. Saeki, S. Tomari, Kazuko Mitsuta-Izaki, H. Matsuse, M. Kinoshita, S. Kohno (2003)
Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthmaClinical Pharmacology & Therapeutics, 73
N. Murayama, A. Soyama, Yoshiro Saito, Y. Nakajima, K. Komamura, K. Ueno, S. Kamakura, M. Kitakaze, Hideo Kimura, Y. Goto, O. Saitoh, Masaaki Katoh, Teiichi Ohnuma, Mitsuru Kawai, K. Sugai, Taisuke Ohtsuki, Chieko Suzuki, N. Minami, S. Ozawa, J. Sawada (2004)
Six Novel Nonsynonymous CYP1A2 Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant EnzymesJournal of Pharmacology and Experimental Therapeutics, 308
S. Hamdy, M. Hiratsuka, K. Narahara, Naomi Endo, Mervat El-Enany, Nadia Moursi, M. Ahmed, M. Mizugaki (2003)
Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.British journal of clinical pharmacology, 55 3
Marilyn Cornelis, A. El-Sohemy, Hannia Campos (2004)
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarctionJournal of Medical Genetics, 41
C. Sachse, J. Brockmöller, S. Bauer, I. Roots (1999)
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.British journal of clinical pharmacology, 47 4
E. Aklillu, J. Carrillo, E. Makonnen, Karin Hellman, M. Pitarque, L. Bertilsson, M. Ingelman-Sundberg (2003)
Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.Molecular pharmacology, 64 3
M. McManus, W. Burgess, M. Veronese, A. Huggett, L. Quattrochi, R. Tukey (1990)
Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.Cancer research, 50 11
M. Landi, Rashmi Sinha, Lang Np, F. Kadlubar (1999)
Human cytochrome P4501A2.IARC scientific publications, 148
G. Hammons, Y. Yan-Sanders, Bo Jin, Ernice Blann, F. Kadlubar, Beverly Lyn-Cook (2001)
Specific site methylation in the 5'-flanking region of CYP1A2 interindividual differences in human livers.Life sciences, 69 7
D. Allorge, D. Chevalier, J. Lo-Guidice, C. Cauffiez, F. Suard, P. Baumann, C. Eap, F. Broly (2003)
Identification of a novel splice-site mutation in the CYP1A2 gene.British journal of clinical pharmacology, 56 3
M. Nakajima, M. Nakajima, T. Yokoi, T. Yokoi, M. Mizutani, M. Kinoshita, M. Funayama, T. Kamataki (1999)
Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.Journal of biochemistry, 125 4
T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, F. Guengerich (1994)
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.The Journal of pharmacology and experimental therapeutics, 270 1
Cytochrome P450 (CYP) 1A2 gene is involved in the metabolic activation of several carcinogens and altered metabolization of some clinically used drugs. We aimed to investigate the distributions of genetic polymorphisms-3860 (G/A)(CYP1A2*1C) and-2467 (T/del)(CYP1A2*1D) in the 5′-flanking region and-739 (T/G)(CYP1A2*1E) and-163(C/A)(CYP1A2*1F) in the first intron of the CYP1A2 gene in 110 unrelated healthy Turkish volunteers by PCR-RFLP technique. The frequencies of each polymorphism in Turkish population were found as 0.04, 0.92, 0.01, 0.27 for CYP1A2*1C, CYP1A2*1D, CYP1A2*1E, CYP1A2*1F, respectively. Compared with other populations, CYP1A2*1Dhas been found to be significantly increased in Turkish population. On the other hand, in general, the frequencies of the other polymorphisms were concordant with those in the Egyptian and Caucasian populations, and were different from those in the Japanese, Chinese and Ethiopian populations. Our results suggest that due to increased frequency of CYP1A2*1D in Turkish population, unctional significance of CYP1A2*1D should be evaluated. It might be screened to determine the relationship between CYP1A2*1D and CYP1A2 related drug metabolisms in associated groups.
Russian Journal of Genetics – Springer Journals
Published: Aug 22, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.